Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Testing the Safety and Tolerability of CX-4945 in Patients With Recurrent Medulloblastoma Who May or May Not Have Surgery

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03904862
Recruitment Status : Recruiting
First Posted : April 5, 2019
Last Update Posted : September 24, 2019
Sponsor:
Collaborators:
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Pediatric Brain Tumor Consortium

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : May 1, 2022
Estimated Study Completion Date : May 1, 2022